Cross-modal framework improves drug-drug interaction prediction, highlighting safety in pharmacovigilance and personalized medicine.
Accurately predicting potential drug-drug interactions (DDIs) from multimodal data is critical for medication safety and adverse drug reaction prevention. Existing methods face challenges in modeling long-range dependencies and effectively integrating heterogeneous features from structured molecular data and unstructured text. To address these limitations, we propose C2M-Mamba, a cross-modal framework that integrates convolutional neural networks, Mamba, and cross-Mamba (CroMamba) to capture discriminative features from drug descriptions, SMILES sequences, and social media texts. The model efficiently handles long-range dependencies through state space models while enabling effective cross-modal fusion. Comprehensive evaluations on the DDIExtraction2013 dataset demonstrate that C2M-Mamba outperforms 10 state-of-the-art baselines, achieving 82.37% precision, 80.98% F1-score, and 88.73% AUC. The proposed approach also exhibits robust performance in handling class imbalance and provides interpretable predictions, offering a reliable solution for multimodal DDI prediction with potential applications in pharmacovigilance and personalized medicine.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: